Treatment of the Kasabach-Merritt syndrome with pegylated recombinant human megakaryocyte growth and development factor in mice: Elevated platelet counts, prolonged survival, and tumor growth inhibition
Henk M W Verheul, Dipak Panigrahy, Evelyn Flynn, Herbert M. Pinedo, Robert J. D'Amato
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Treatment of the Kasabach-Merritt syndrome with pegylated recombinant human megakaryocyte growth and development factor in mice: Elevated platelet counts, prolonged survival, and tumor growth inhibition'. Together they form a unique fingerprint.